Cu/dioxidine hybrid nanocomposites: cryochemical synthesis and antibacterial activity

Abstract

Hybrid nanocomposites consisting of an antibacterial drug, dioxidine, and copper nanoparticles are obtained by cryochemical synthesis. It is shown by UV spectroscopy, X-ray diffraction, PAM, and low temperature argon adsorption that the obtained hybrid systems represent dioxidine particles with a size of 100 to 400 nm, including copper particles with the size of 50 to 150 nm. The resulting composites possessed higher antibacterial activity against E. coli 52 than the initial dioxidine and copper nanoparticles.